2013-03-14 08:18:48 -

The Supervisory Board of Royal DSM is pleased to announce that it will propose
to the Annual General Meeting of Shareholders on 3 May 2013 to appoint Mr.
Dimitri de Vreeze to the Managing Board of DSM with responsibility for DSM's
Materials Sciences clusters, with effect from 1 September 2013.

Mr. de Vreeze will succeed Mr. Nico Gerardu, who will be retiring from the
company after a long and rich career in DSM. Mr. Gerardu was appointed to the
Managing Board in 2006, after holding several senior management positions and
serving as Business Group Director of DSM Fine Chemicals and later DSM Anti-
Infectives.

The members of the Supervisory Board and Mr. Gerardu's colleagues on the
Managing Board would like to express their gratitude and thanks for his
leadership throughout his   long career with DSM and for his contributions to the
organization's success.

Dimitri de Vreeze (1967), a Dutch national, is at present Business Group
Director of DSM Resins. He has built a strong team while delivering real
progress in DSM Resins.

Mr. de Vreeze joined DSM in 1990 in Finance in DSM Fine Chemicals. He
subsequently moved to sales management and took on increasingly bigger roles,
including that of Global Business Manager Sizing & Binders based in Italy. In
2002 he became Business Director Composite Resins Europe, based in Switzerland.
Dimitri was Business Unit Director Coating Resins between 2005 and 2007 and
Business Unit Director NeoResins between 2007 and 2010.

Mr. de Vreeze studied Business Economics at the University of Groningen and is
Postgraduate of the Chartered Controllers Program Maastricht.

DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in global
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials. DSM's
23,500 employees deliver annual net sales of around €9 billion. The company is
listed on NYSE Euronext. More information can be found at www.dsm.com.


For more information:

  DSM Corporate Communications          DSM Investor Relations

  Herman Betten                         Dave Huizing
  tel. +31 (0) 45 5782017               tel. +31 (0) 45 5782864
  fax +31 (0) 45 5740680                fax +31 (0) 10 4590275
  e-mail media.relations@dsm.com        e-mail investor.relations@dsm.com







Dimitri de Vreeze-jpg: 
 hugin.info/130663/R/1685214/552022.jpg

Press release-pdf: 
 hugin.info/130663/R/1685214/552020.pdf



This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: DSM N.V.  via Thomson Reuters ONE
[HUG#1685214]